Page last updated: 2024-08-24

triazoles and incb-018424

triazoles has been researched along with incb-018424 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bradner, JE; Johnstone, RW; Jones, LR; Kats, L; Kim, SK; Knight, DA; Ng, AP; Seymour, JF; Vervoort, S; Waibel, M1
Georgiou, S; Plachouri, KM1
Chang, Y; Chen, J; Christiano, AM; Dai, Z1

Reviews

1 review(s) available for triazoles and incb-018424

ArticleYear
JAK inhibitors in chronic plaque psoriasis: What is known so far.
    Drugs of today (Barcelona, Spain : 1998), 2020, Volume: 56, Issue:2

    Topics: Adamantane; Azetidines; Humans; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Nitriles; Piperidines; Prospective Studies; Psoriasis; Purines; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Sulfonamides; Triazoles

2020

Other Studies

2 other study(ies) available for triazoles and incb-018424

ArticleYear
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias.
    Genes & development, 2018, 06-01, Volume: 32, Issue:11-12

    Topics: Animals; Antineoplastic Agents; Azepines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Knockdown Techniques; Humans; Janus Kinase 2; Male; Mice; Mutation; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; Receptors, Cytokine; RNA Interference; Transcriptome; Triazoles

2018
Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata.
    JCI insight, 2021, 04-08, Volume: 6, Issue:7

    Topics: Administration, Topical; Alopecia Areata; Animals; Azetidines; CD8-Positive T-Lymphocytes; Cytokines; Isonicotinic Acids; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Macrophages; Mice, Inbred C3H; Nitriles; NK Cell Lectin-Like Receptor Subfamily K; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Triazoles

2021